Revenue: As of FY2025 Q1, the actual value is USD 86.44 M.EPS: As of FY2025 Q1, the actual value is USD -0.18.<h3>Outpatient Medical Facilities (OMFs) Segment</h3><ul><li>Revenue from Tenants: $30.6 million for the three months ended March 31, 2025, compared to $34.6 million for the same period in 2024, a decrease of 11.5%.</li><li>Property Operating and Maintenance Expenses: $11.2 million for the three months ended March 31, 2025, compared to $9.7 million for the same period in 2024, an increase of 15.1%.</li><li>Net Operating Income (NOI): $19.5 million for the three months ended March 31, 2025, compared to $24.9 million for the same period in 2024, a decrease of 21.8%.</li></ul><h3>Seniors Housing Operating Properties (SHOPs) Segment</h3><ul><li>Revenue from Tenants: $55.8 million for the three months ended March 31, 2025, compared to $53.7 million for the same period in 2024, an increase of 3.9%.</li><li>Property Operating and Maintenance Expenses: $46.4 million for the three months ended March 31, 2025, compared to $45.4 million for the same period in 2024, an increase of 2.0%.</li><li>Net Operating Income (NOI): $9.4 million for the three months ended March 31, 2025, compared to $8.3 million for the same period in 2024, an increase of 14.3%.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: -$21.2 million for the three months ended March 31, 2025, compared to $2.5 million provided in the same period in 2024.</li><li>Net Cash Provided by Investing Activities: $78.0 million for the three months ended March 31, 2025, compared to -$12.2 million used in the same period in 2024.</li><li>Net Cash Used in Financing Activities: -$4.5 million for the three months ended March 31, 2025, compared to -$5.2 million used in the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to fund future short-term operating liquidity requirements through a combination of current cash on hand, net cash provided by operating activities, potential future advances under Fannie Mae Master Credit Facilities, net cash provided by property dispositions, and potential new financings utilizing currently unencumbered properties.</li><li>Non-Core Business: The company disposed of 12 held-for-use OMFs during the three months ended March 31, 2025, for an aggregate contract sales price of $168.4 million, resulting in an aggregate gain on sale of $25.0 million.</li></ul><h3>Additional Metrics</h3><ul><li>Interest Expense: $14.5 million for the three months ended March 31, 2025, compared to $16.4 million for the same period in 2024, a decrease of $1.9 million.</li><li>Depreciation and Amortization: $23.7 million for the three months ended March 31, 2025, compared to $20.7 million for the same period in 2024, an increase of $3.0 million.</li></ul>

National Healthcare Pref Share HTIBP 7.125 Perp 10/06/26 B | 10-Q: FY2025 Q1 Revenue: USD 86.44 M